Ampio provides update on covid-19 clinical trial activities

Ampio provides update on covid-19 clinical trial activities.ampio pharmaceuticals inc - fda requested comprehensive tests on safety of nebulized ampion at various doses.ampio - a clinical trial protocol for treating patients who have respiratory distress due to covid-19 with nebulized ampion is being reviewed by fda.
AMPE Ratings Summary
AMPE Quant Ranking